skip to Main Content

November 16, 2022
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).

November 10, 2022
Public Comment Submitted to the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
Letter / Comment
Comment submitted prior to their meeting on November 17, 2022. Comment is in regard to discussion and voting on recommendation related to implementation of the HIV Organ Policy Equity (HOPE) Act of 2013, specifically pertaining to HIV-positive to HIV-positive organ transplantation and pertaining to the following draft recommendation under consideration…

November 3, 2022
TAGline November 2022
TAGline
This year’s edition of TAGline commemorates TAG’s 30th anniversary, and these articles explore TAG’s work over the years: what we’ve accomplished, what we’ve learned, the continuing obstacles to progress, and what comes next.

October 27, 2022
Community Mobilization to Ensure Health Systems’ Readiness for Long-Acting Therapies
Webinar / Presentation
On November 16, 2022, please join TAG, INPUD and AfroCAB for our webinar “Community Mobilization to Ensure Health Systems’ Readiness for Long-Acting Therapies” at 8:00 a.m. EST / 02:00 p.m. CET / 05:30 IST. 

October 20, 2022
Treatment Action Group Resource on the Demographics of Participation in HIV Cure-Related Clinical Research
In 2014, TAG began tracking HIV cure-related trials and observational studies and making the information available as a listing on our website. The primary sources are online study registries, particularly the US-based clinicaltrials.gov.

October 19, 2022
Towards Pandemic Equity: Lessons from 30 Years of Syndemic Activism
TAGline
By Mike Frick and Mark Harrington The articles in this 30th anniversary issue of TAGline grapple with “pandemic equity,” an increasingly common catchphrase in global health. COVID-19 has shown that “equity,” like its cousins “justice,” “fairness,” and “equality,” is one of those words whose use rises in proportion to its…

October 6, 2022
Treatment Action Group Statement: U.S. District Court Ruling Allowing Employers to Deny PrEP Coverage Is a Dangerous Attack on Public Health
Statement / Press
Treatment Action Group (TAG)  unequivocally condemns the September 2022 U.S. District Court ruling in Fort Worth, Texas on the case Braidwood Management Inc. et al., v. Xavier Becerra et al., which ruled that the Affordable Care Act’s requirement that employers cover pre-exposure prophylaxis (PrEP) for HIV prevention was unconstitutional.

October 5, 2022
Digital Communications Consultant
Treatment Action Group (TAG) is seeking to engage a creative, highly motivated Digital Communications Consultant.

October 4, 2022
Chief Operating Officer
Treatment Action Group (TAG) is seeking a dynamic, seasoned, and strategic leader to become TAG’s Chief Operating Officer, supporting the organization as it continues to grow.

September 21, 2022
The LAT CAB Responds to MedinCell and Medicines Patent Pool License on a New Long-Acting Malaria Formulation
Statement / Press
As the global Long-Acting Technologies Community Advisory Board (LAT CAB) representing vast civil society networks, and people living with and affected by malaria, HIV, tuberculosis, and the hepatitis C virus (HCV) across the world, we welcome the efforts leading to the development of an investigational long-acting injectable (LAI) formulation of…

August 24, 2022
Pathways Forward to End HIV: How HIV Cure Research is Helping to Advance HIV Vaccine Research
Webinar / Presentation
On September 20, please join Treatment Action Group, Dr. Shelly Karuna, and Dr. Karine Dubé for a webinar on the next generation of bnAbs trial design and ethics related to ATIs in HIV vaccine and cure research.

August 23, 2022
Treatment Action Group Statement on Retirement of Dr. Anthony S. Fauci
Statement / Press
Treatment Action Group (TAG) meets with sadness the announcement by Dr. Anthony S. Fauci of his retirement as Director of the National Institute of Allergy and Infectious Diseases (NIAID), Chief of the NIAID Laboratory of Immunoregulation, and Chief Medical Advisor to President Biden, effective in December 2022.

August 23, 2022
Treatment Action Group Adds Three New Board Members
Statement / Press
As it celebrates its 30th Anniversary year, Treatment Action Group (TAG) announced the election of David Puente, Michael Montero and Ivy Kwan Arce to its Board of Directors.

July 24, 2022
2022 Pipeline Report
Pipeline Report
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).

July 8, 2022
Research in Action Awards 2022
Save the date for Tuesday, November 16, 2021! TAG’s 2021 Research in Action Awards will honor some of the best and brightest activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C across the U.S. and around the world. This year we’ll once again gather virtually…

Back To Top